| EP1309692 - ANTI-IL-12 ANTIBODIES, COMPOSITIONS, METHODS AND USES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 19.03.2010 Database last updated on 07.04.2026 | Most recent event Tooltip | 19.03.2010 | No opposition filed within time limit | published on 21.04.2010 [2010/16] | Applicant(s) | For all designated states Centocor Ortho Biotech Inc. 800/850 Ridgeview Drive Horsham, PA 19044 / US | [N/P] |
| Former [2009/24] | For all designated states Centocor Ortho Biotech, Inc. 800/850 Ridgeview Drive Horsham, PA 19044 / US | ||
| Former [2009/20] | For all designated states CENTOCOR, INC. 200 Great Valley Parkway Malvern, PA 19355 / US | ||
| Former [2003/20] | For all designated states Centocor, Inc. 200 Great Valley Parkway Malvern, PA 19355 / US | Inventor(s) | 01 /
GILES-KOMAR, Jill 31 Blakely Road Downingtown, PA 19355 / US | 02 /
KNIGHT, David, M. 2430 Whitehorse Road Berwyn, PA 19312 / US | 03 /
PERITT, David 407 Conshohocken State Road Bala Cynwyd, PA 19004 / US | 04 /
SCALLON, Bernard 139 Hemlock Drive Collegeville, PA 19426 / US | 05 /
SHEALY, David 1351 Penns Ridge Place Downingtown, PA 19335 / US | [2003/20] | Representative(s) | Mercer, Christopher Paul, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2003/20] | Mercer, Christopher Paul, et al Carpmaels & Ransford 43, Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 01959598.2 | 07.08.2001 | [2003/20] | WO2001US24720 | Priority number, date | US20000223358P | 07.08.2000 Original published format: US 223358 P | US20000236827P | 29.09.2000 Original published format: US 236827 P | US20010920262 | 01.08.2001 Original published format: US 920262 | [2003/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0212500 | Date: | 14.02.2002 | Language: | EN | [2002/07] | Type: | A2 Application without search report | No.: | EP1309692 | Date: | 14.05.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.02.2002 takes the place of the publication of the European patent application. | [2003/20] | Type: | B1 Patent specification | No.: | EP1309692 | Date: | 13.05.2009 | Language: | EN | [2009/20] | Search report(s) | International search report - published on: | EP | 03.01.2003 | Classification | IPC: | C12N15/13, C07K16/24, C12N15/79, C12N5/10, A61K39/395, C07K16/42, A61P37/00, G01N33/50, G01N33/577 | [2003/20] | CPC: |
C07K16/244 (EP,US);
C07K16/24 (KR);
A61K39/3955 (US);
A61K45/06 (US);
A61P1/00 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P21/02 (EP);
A61P23/00 (EP);
A61P23/02 (EP);
A61P25/00 (EP);
A61P25/20 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P31/00 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P37/04 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61K2039/505 (EP,US);
C07K2317/21 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/20] | Extension states | AL | Not yet paid | LT | 06.03.2003 | LV | 06.03.2003 | MK | Not yet paid | RO | 06.03.2003 | SI | 06.03.2003 | Title | German: | ANTIKÖRPER GEGEN IL-12, ZUSAMMENSETZUNGEN, VERFAHREN UND VERWENDUNGEN | [2003/20] | English: | ANTI-IL-12 ANTIBODIES, COMPOSITIONS, METHODS AND USES | [2003/20] | French: | ANTICORPS, COMPOSITIONS, PROCEDES ANTI-IL-12 ET LEUR UTILISATION | [2003/20] | Entry into regional phase | 06.03.2003 | National basic fee paid | 06.03.2003 | Designation fee(s) paid | 06.03.2003 | Examination fee paid | Examination procedure | 07.03.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 06.03.2003 | Examination requested [2003/20] | 07.03.2003 | Amendment by applicant (claims and/or description) | 01.02.2006 | Despatch of a communication from the examining division (Time limit: M06) | 01.08.2006 | Reply to a communication from the examining division | 08.02.2008 | Despatch of a communication from the examining division (Time limit: M06) | 08.08.2008 | Reply to a communication from the examining division | 21.11.2008 | Despatch of a communication from the examining division (Time limit: M02) | 29.01.2009 | Reply to a communication from the examining division | 09.03.2009 | Communication of intention to grant the patent | 19.03.2009 | Fee for grant paid | 19.03.2009 | Fee for publishing/printing paid | Divisional application(s) | EP09006396.7 / EP2090657 | EP10184116.1 / EP2305817 | EP17153336.7 / EP3178934 | EP19179253.0 | Opposition(s) | 16.02.2010 | No opposition filed within time limit [2010/16] | Fees paid | Renewal fee | 06.03.2003 | Renewal fee patent year 03 | 12.08.2004 | Renewal fee patent year 04 | 12.08.2005 | Renewal fee patent year 05 | 14.08.2006 | Renewal fee patent year 06 | 14.08.2007 | Renewal fee patent year 07 | 31.03.2008 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X] WO9715327 (US HEALTH et al.) [X] 1-101 * page 5, lines 5-15 * * examples 5,6 * | [A] WO9633735 (CELL GENESYS INC et al.) [A] 1-101 * page 1, line 31 - page 3, line 30 * * page 15, line 6 * | [X] WO9937682 (HOFFMANN LA ROCHE et al.) [X] 1-101 * page 2, line 20 - page 3, line 16 * * page 14, lines 15-24 * | [PX] WO0056772 (BASF AG et al.) [PX] 1-101 * page 2, line 26 - page 5, line 14 * * example 1 * | [A] YAWALKAR NIKHIL ET AL: "Expression of interleukin-12 is increased in psoriatic skin.", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 111, no. 6, December 1998 (1998-12-01), pages 1053 - 1057, XP008005771, ISSN: 0022-202X [A] 16,36,56,76,96 * abstract * DOI: http://dx.doi.org/10.1046/j.1523-1747.1998.00446.x | Examination | EP0640689 | PADLAN E.A.: "Anatomy of the antibody molecule", MOLECULAR IMMUNOLOGY, vol. 31, no. 3, 1994, pages 169 - 217, XP023620599 DOI: http://dx.doi.org/10.1016/0161-5890(94)90001-9 |